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Background: The genetics of autism spectrum disorder (hereafter referred to as “autism”) are rapidly unfolding, with a
significant increase in the identification of genes implicated in the disorder. Many of these genes are part of a complex
landscape of genetic variants that are thought to act together to cause the behavioral phenotype associated with
autism. One of the few single-locus causes of autism involves a mutation in the SH3 and multiple ankyrin repeat
domains 3 (SHANK3) gene. Previous electrophysiological studies in mice with Shank3 mutations demonstrated
impairment in synaptic long-term potentiation, suggesting a potential disruption at the synapse.
Methods: To understand how variants in SHANK3 would lead to such impairments and manifest in the brain of
patients with autism, we assessed the presence of synaptic pathology in Shank3-deficient mice at 5 weeks and
3 months of age, focusing on the stratum radiatum of the CA1 field. This study analyzed both Shank3 heterozygous
and homozygous mice using an electron microscopy approach to determine whether there is a morphological
correlate to the synaptic functional impairment.
Results: As both synaptic strength and plasticity are affected in Shank3-deficient mice, we hypothesized that there
would be a reduction in synapse density, postsynaptic density length, and perforated synapse density. No differences
were found in most parameters assessed. However, Shank3 heterozygotes had significantly higher numbers of
perforated synapses at 5 weeks compared to 3 months of age and significantly higher numbers of perforated synapses
compared to 5-week-old wildtype and Shank3 homozygous mice.
Conclusions: Although this finding represents preliminary evidence for ultrastructural alterations, it suggests that while
major structural changes seem to be compensated for in Shank3-deficient mice, more subtle morphological alterations,
affecting synaptic structure, may take place in an age-dependent manner.
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The behavioral symptoms that currently define autism
have yet to be rooted in a cause, though it is generally
understood that these symptoms originate from alter-
ations in the brain. Many studies have validated this
hypothesis, as regionally specific abnormalities including
reduced neuronal size, decreased neuronal number, and
cortical disorganization are present in individuals with
autism (e.g., [1–6]). The abnormalities in neuronal* Correspondence: patrick.hof@mssm.edu
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nication among neurons, which likely manifest at the
synapse. Of particular relevance is the growing number
of synaptic function-related genes implicated in autism.
The Src homology 3 and multiple ankyrin repeat do-
mains 3 (SHANK3) gene, which encodes for the postsyn-
aptic scaffolding protein SHANK3/ProSAP2, has been
identified as one of the few genes which can by itself
lead to autism when mutated. SHANK3 was identified as
the cause of the neurobehavioral manifestations of the
22q13 deletion syndrome, or the Phelan-McDermid
syndrome (PMS; [7]). Patients with PMS not only exhibit
developmental, intellectual, and language delays as well
as motor deficits but also frequently demonstrate autisticticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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tions have varying deletion sizes, SHANK3 is a gene that
has been consistently implicated [12] and was later found
to be exclusively affected through point mutations in some
individuals with PMS [10, 13–15], leading to the conclu-
sion that this gene is likely a strong candidate gene for
autism as well. Upon further analysis, SHANK3 variants
were identified in patients ascertained with autism [9, 11,
13, 16–18]. Given its crucial role in the etiology of PMS
and autism, studying the impact of a loss of SHANK3 will
allow for a detailed assessment of cellular and molecular
mechanisms that underlie pathology.
SHANK3 belongs to a family of SHANK proteins, all of
which have multiple domains for protein-protein inter-
action [19, 20]. Each of these domains interacts with spe-
cific proteins, in particular with cytoskeletal proteins, cell
adhesion proteins, and ionotropic and metabotropic glu-
tamate receptors [21–25], some of which are also impli-
cated in autism (e.g., NLGN3, NLGN4, SHANK1,
SHANK2). SHANK3 is strongly expressed at the postsyn-
aptic density (PSD), as it is part of a molecular assembly
(which includes PSD-95/GKAP/Shank/Homer) which
comprises approximately 27 % of the total protein mole-
cules in the PSD; Shank3 is estimated to comprise ~5 % of
the total protein molecules in the PSD [26]. To determine
the effect of a loss of one copy of SHANK3, as observed in
patients with PMS [11], Bozdagi and colleagues [27] cre-
ated a mouse with a disruption in full-length Shank3,
which is a form known to be specifically disrupted in pa-
tients with autism (e.g., [18]). Functionally, the authors
demonstrated that Shank3 heterozygotes display signifi-
cant impairments in long-term potentiation (LTP) main-
tenance when recording from the stratum radiatum in the
CA1. Furthermore, they reported a significant decrease in
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) receptor-mediated field potentials in the Shank3
heterozygotes as well as a reduction in the amount of glu-
tamate receptor subunit 1 (GluA1), an AMPA receptor
subunit. Subsequently, Yang and colleagues [28] corrobo-
rated the electrophysiologic impairments in Shank3 het-
erozygous mice and found impairments in both LTP
induction and maintenance in Shank3 homozygous mice.
While Shank3 protein is widely expressed throughout the
brain, it is concentrated in the thalamus, cerebellum, and
hippocampus [29]. Because of the impairment in LTP seen
in Shank3 heterozygous and homozygous mice, Shank3
expression in the hippocampus was particularly interest-
ing to assess.
Given these findings and the crucial role of SHANK3
in the etiology of PMS and autism, this study examined
ultrastructural alterations in the above Shank3 mouse
model of autism. The primary morphological parameters
assessed in the current study were synapse density, per-
forated synapse density, and PSD length in the Shank3-deficient mice, due to the likelihood these parameters
would be affected by a loss of Shank3, given its role in
the PSD and LTP (e.g., [27, 30]). Differences in PSD
length would indicate a change in the ratio of plastic
and stable spines, as PSD length is correlated with spine
head size and type. We also assessed perforated synap-
ses, which are distinguished by a discontinuous PSD des-
pite being part of a single synapse. Perforated synapses
have been implicated in many functions in the context
of learning and memory, including maintenance of
spatial learning ability, activity-dependent synaptic plas-
ticity, and LTP induction [31–35]. The formation of a
perforation in the synapse, which transiently occurs dur-
ing LTP induction, is thought to enhance the efficacy of
synaptic transmission due to the increase in PSD area
and therefore increase in AMPA- and N-methyl-D-
aspartic acid (NMDA)-receptor content [33, 34, 36].
Their formation, however, remains a subject of debate,
with some postulating that non-perforated synapses be-
come perforated, as a transient intermediary structure,
to then form two separate synapses (for example, [37]),
others postulating that perforated and non-perforated
synapses are completely separate populations of synapses
that develop in unique ways (for example, [38]), and
others suggesting that perforations transiently develop in
non-perforated synapses to briefly increase the efficacy
of the synapse, which will later form back into its ori-
ginal non-perforated structure (for example, [39]). Des-
pite the debate on perforated synapse origin and
development, their role in increasing the efficacy of a
synapse is generally agreed upon and is the reason we
are assessing their presence in our mouse model.
Changes in synapse functioning, as measured through
morphological changes, would likely lead to alterations
in normal neuronal functioning. Alterations in neuronal
functioning, in turn, might be reflected in the behavioral
changes that currently characterize individuals with dis-
orders such as PMS and autism. There are very few
studies that have assessed hippocampal differences in
postmortem brains from this patient population and that
have identified neuronal abnormalities that may affect
synaptic functioning. Neuronal abnormalities in the
hippocampus in patients with autism include reduction
in neuron volume, dendritic branching, and nucleus vol-
ume [3, 6], although to our knowledge there are no stud-
ies that have quantified changes at the synaptic level in
patients with autism. Unfortunately, as of yet, there have
been no postmortem studies in individuals with PMS
nor specifically on individuals with autism that have a
disruption in SHANK3; however, we can presume that
this region is likely also affected in these individuals, as
they present with similar behavioral symptoms.
In the current study, synaptic measures were assessed
at two time points: 5 weeks, corresponding to an early
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vant brain region is undergoing constant synaptic prun-
ing, and 3 months, corresponding to a young adult that
is socially mature and has a reduced rate of synaptic
turnover. These ages were consistent with previous stud-
ies conducted on this mouse model [27, 28], which
allowed for direct comparison of the synaptic measures
in this study with electrophysiological and behavioral
measures from earlier studies. Overall, this study aimed




All procedures were compliant with the National Insti-
tute of Health Guidelines for the Care and Use of Ex-
perimental Animals and were approved by the
Institutional Animal Care and Use Committee at theFig. 1 The disector method. a Representative picture of a reference and
reference and B as lookup; note the inclusion (green) and exclusion (red)
in both the reference and lookup sections are not counted towards syna
pre- or postsynapse touch the exclusion lines (synapse 6; red). Each uniqu
the rest of the series to identify perforated synapses (red asterisk; b) and m
spine head size, indicated by blue lines (d). Scale bar = 500 nmIcahn School of Medicine at Mount Sinai. Shank3 het-
erozygous and homozygous mice were generated using
homologous recombination to delete the ankyrin repeat
domain of Shank3. This constitutive knockout mouse
model of Shank3 disruption has been previously charac-
terized in detail [27, 28]. The study included 15 C57BL/
6 male mice (5 weeks old: 5 Shank3 homozygous mice, 5
Shank3 heterozygous mice, and 5 wildtype mice) and 15
C57BL/6 male mice (3 months old: 5 Shank3 homozy-
gous mice, 5 Shank3 heterozygous mice, and 5 wildtype
mice). Mice were group-housed and were given standard
mouse chow and water ad libitum.
Perfusion and tissue processing
Prior to perfusion, mice were anesthetized with 15 %
chloral hydrate. The mice were perfused with 1 % cold
paraformaldehyde (pH 7.2–7.4) in phosphate buffer sa-
line (PBS) for 1.5 min. This was followed by a solutionlookup section in a set of serial images labeled A–E, with A as
lines bordering the boundaries of images. Synapses that are present
pse density (synapses 2 and 4; yellow) nor are synapses in which the
e synapse in the lookup section (synapse 5; blue) is followed through
easure postsynaptic density length, indicated with pink lines (c), and
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glutaraldehyde for 10.5 min at 5 ml/min. The brain was
then removed from the skull and postfixed in a 4 %
paraformaldehyde/0.125 % glutaraldehyde solution over-
night at 4 °C. The brain was washed in phosphate buffer
(PB), cut into 250-μm-thick sections using a vibratome,
and stored in PB overnight. The sections were cryopro-
tected the next day in a graded glycerol/PB solution.
After remaining in a 30 % glycerol solution overnight,
the CA1 was manually microdissected into blocks
(four per animal) that underwent cryosubstitution and
low-temperature embedding as described in [40].
Once the polymerization was complete, the hardened
capsules were removed from the cryosubstitution system
and stored at room temperature. Block faces were
trimmed to include the stratum pyramidale, stratum
radiatum, stratum lacunosum-moleculare, and white
matter. At least eight consecutive ultrathin sections were
cut at 90 nm with a diamond knife (Diatome, Bienne,
Switzerland) on an ultramicrotome (Reichert-Jung) and
mounted onto a Formvar-supported slot grid (Electron
Microscopy Sciences).
Morphological analysis
Serial section imaging was carried out at 75 kV on a Hitachi
H-7000 transmission electron microscope (Hitachi High
Technologies America) with an AMT Advantage CCDFig. 2 Synapse density and perforated synapse density across ages and ge
old mice (left) and 3-month-old mice (right). A significant increase in perfor
(left), but no difference was seen at 3 months (right). Standard deviation in
*denotes significancecamera (Advanced Microscopy Techniques). Eight sets of
five serial sections of distinct regions in the stratum radia-
tum of the CA1 were imaged at ×15,000. Electron micro-
graphs were adjusted for brightness, contrast, and
sharpness using Adobe Photoshop (Photoshop CS4, version
11.0.2) prior to being analyzed. All morphological analysis
was carried out in Adobe Photoshop.
Synapse density and perforated synapse density were
analyzed using the disector method (Fig. 1; [41]). Asym-
metric axospinous synapses were defined as having an
asymmetric PSD, presynaptic vesicles, a clear synaptic
cleft, and an evident spine head. All synapses present in
the first (“reference”) section, but not the second
(“lookup”), were used for calculations of synapse density,
along with each synapse that was present in the second
section, but not the first. To calculate perforated synapse
density, all unique synapses from the second section
were followed through the remaining three sections to
determine whether the synapses were perforated
(defined as a clear break in the PSD). PSD length was
measured in each section with a resolution of 0.5 μm/
113 pixels. The longest measured PSD length was used
as the representative measure for that synapse. This
process was also completed for spine head size, measur-
ing the widest point of the spine head parallel to the
PSD. The longest length of spine head was used as the
representative measure of that synapse. This entirenotypes. No change in density of synapses (a) was found in 5-week-
ated synapses (b) is shown in 5-week-old Shank3 heterozygous mice
dicated with vertical black lines, mean indicated by horizontal black line;
Fig. 3 Increased perforated synapses in Shank3 heterozygous mice
at 5 weeks old. Representative photomicrograph of a serial section
in a Shank3 homozygote (a) Shank3 heterozygote (b), and wildtype
(c). Note the increased number of perforated synapses, shaded in
blue, present in (b). Scale bar = 500 nm
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two sections as the reference and lookup sections; this
allowed for approximately 400–600 synapses recorded
per animal. The disector area was 58.65 μm2, and disec-
tor height was 180 nm; therefore, the synapse density
was calculated as the total number of counted synapses
from both the first and second sections divided by the
total volume of the disector (10.56 μm3).
Statistical analysis
We compared two ages and three genotypes of mice. Both
the 5-week and 3-month group had an n = 5 per genotype,
with a total of 15 mice each. Comparisons of potential
genotypic variations within one age group were deter-
mined using one-way analysis of variance (ANOVA). To
reduce type I error while comparing several means, a
Tukey post hoc test was used to calculate whether there
were significant differences between pairs of genotypes.
Calculations were performed with GraphPad Prism
(version 5). To determine whether there was an inter-
action between age and genotype on the parameters
assessed, we used two-way ANOVA to assess for signifi-
cant differences and corrected for multiple comparisons
using the Tukey post hoc test. Calculations were per-
formed with SPSS (version 20). A p value of 0.05 was used
as the criterion for statistical significance.
Results
The first measure of synaptic pathology we assessed in
these mice was overall synaptic density and perforated
synapse density. No difference was found in synapse dens-
ity between Shank3 heterozygous, Shank3 homozygous,
and wildtype 5-week-old mice (F(2,12) = 1.915, p = 0.19;
Fig. 2a). This result remained consistent into adulthood,
with 3-month-old mice also showing no difference in
synapse density across the three genotypes (F(2,12) = 1.256,
p = 0.32; Fig. 2a), though 5-week-old mice had significantly
greater synapse density than 3-month-old mice (p = 0.002).
There was no significant interaction between genotype and
age for synapse density (F(2,24) = 2.254, p = 0.127). However,
perforated synapse density was significantly different in 5-
week-old mice across genotypes (F(2,12) = 15.09, p = 0.0005),
with significantly higher perforated synapse density in
Shank3 heterozygous mice as compared to wildtype and
Shank3 homozygous mice (p < 0.05; Figs. 2b and 3). This
increase did not persist into adulthood, as 3-month-old
mice did not have significant differences across genotypes
in perforated synapse density (F(2,12) = 3.047, p = 0.085;
Fig. 2b). A two-way ANOVA revealed a significant inter-
action between age and genotype in perforated synapse
density (F(2,24) = 10.569, p = 0.001). To follow up on this
interaction, we carried out a one-way ANOVA controlling
for age, with genotype as a factor. As expected, there was a
significant difference in perforated synapse density betweengenotypes (F(2, 479) = 17.85, p < 0.001). A Tukey post hoc test
revealed that Shank3 heterozygotes had significantly greater
perforated synapse density than wildtype (p < 0.001) and
Shank3 homozygotes (p < 0.001), though the difference was
not significant between wildtype and Shank3 homozygotes
(p = 0.848).
We then analyzed 5-week-old and 3-month-old mice
for changes in spine head size, length of the PSD, and
area of the PSD. There was no difference in average
spine head size in the 5-week-old mice (F(2,12) = 0.551,
p = 0.59; Fig. 4a) or 3-month-old mice (F(2,12) = 0.899,
p = 0.433, Fig. 4a) nor was there an interaction effect of
age and genotype on spine head size (F(2,24) = 1.243,
p = 0.306). There was no significant difference between
genotypes in the PSD length in 5-week-old mice
(F(2,12) = 0.976, p = 0.405; Fig. 4b), 3-month-old mice
(F(2,12) = 3.477, p = 0.064, Fig. 4b), or across develop-
ment (F(2,24) = 2.308, p = 0.121). PSD area was also the
same across genotypes in 5-week-old mice (F(2,12) =
0.714, p = 0.509, Fig. 4c), 3-month-old mice (F(2,12) =
Fig. 4 No change in morphologic measures across ages and genotypes. No change was found in spine head size (a), postsynaptic density length
(b), or postsynaptic density area (c) in 5-week-old mice (left column) and in 3-month-old mice (right column). Standard deviation indicated with
vertical black lines, mean indicated by horizontal black line
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tal stages (F(2,24) = 3.021, p = 0.068).
Discussion
The Shank family of postsynaptic scaffolding proteins con-
sists of three members (Shank1, Shank2, and Shank3;
[21, 22]). Shank1 and Shank3 mRNA transcripts are
strongly expressed in the pyramidal and molecular layers
of the hippocampus, indicating dendritic localization,
whereas Shank2 mRNA transcripts are restricted to cell
bodies [29, 42]. Shank2 protein localizes at the PSD early
(prior to PSD-95 and NR1; [30]) and is thought to act as
an initial “organizer” of the PSD; Shank3 is recruited next,
interacting with Homer1b to create a complex on which
postsynaptic proteins, such as GKAP, can bind [43]; lastly,Shank1 enters after the PSD-95/GKAP complex is in place
to stabilize synapses and may have a role in activity-
induced regulation of spine head size [22, 44, 45].
With the loss of a major synaptic scaffolding protein,
we expected to find significant morphologic changes in
the Shank3-deficient mice. However, Shank3 heterozy-
gous and homozygous mice exhibited no difference in
spine head size, PSD length, and PSD area when com-
pared to wildtype mice. This result suggests that the ab-
sence of Shank3 may be compensated for or may lead to
deficits that are only observed early in development.
Two obvious candidates for this compensation are
Shank1 and Shank2. Shank2 is more similar to Shank3
in its recruitment to the synapse and its protein struc-
ture, making it a more likely candidate for compensation
Uppal et al. Molecular Autism  (2015) 6:41 Page 7 of 10[20]. In fact, Shank3 was thought to compensate for
Shank2 in Shank2-deficient mice, while Shank2 was
thought to compensate for Shank3 in another form of
Shank3 variant homozygous mice, as indicated by the
upregulation of Shank3 at the synapse in Shank2 homo-
zygous mice and vice versa [46].
In Shank3 heterozygotes, there is still one functional
copy of Shank3, and therefore, a proportional amount
of Shank3 protein is present at the synapse [27]. A re-
duced amount of Shank3 could affect multiple associ-
ated proteins [20, 22, 43, 44, 47] and may result in
changes in protein composition at the synapse, which
may explain functional impairment in Shank3 heterozy-
gous and homozygous mice [27, 28, 48]. While the
Shank family does have highly conserved protein-
protein interaction domains, they are not redundant;
each Shank protein can have specific mechanisms and
proteins it targets [20]. Thus, while replacing one
Shank protein with another might prevent the synapse
from disassembling, it does not guarantee appropriate
functioning. This is well illustrated through the mild be-
havioral abnormalities in these mice, consistently showing
impairments in juvenile reciprocal interactions, novel ob-
ject recognition, and rotarod performance [27, 28]. TheFig. 5 Schematic of suggested mechanism of increased perforated synapse d
non-perforated and perforated synapses. b Shank3 heterozygous mice have a
non-perforated synapses due to impaired LTP maintenance. c Shank3 homoz
may be why the increase in perforated synapses, which is thought to be com
synapses; gray synapses indicate silent synapses; black synapses with perforatio
are impairedmice also showed some evidence for excess self-grooming,
reduced ultrasonic vocalizations, and impaired reversal of
water maze learning.
The fact that synapse density was not changed despite
the marked LTP deficit may reflect that a portion of the
synapses in Shank3 variant mice may be “silent synap-
ses” that have NMDA but not AMPA receptors, render-
ing the synapse non-functional [49]. Silent synapses are
present in wildtype mice as well, forming during LTP
induction and often undergoing remodeling to become
functional during LTP maintenance [50, 51]. It is pos-
sible that to compensate for the increase in silent
synapses in Shank3-deficient mice at baseline, some si-
lent synapses undergo remodeling to form perforated
synapses, which are thought to have a higher efficacy of
synaptic transmission [52, 53]. The presence of in-
creased silent synapses is corroborated by reduced basal
synaptic transmission in both Shank3 heterozygous and
homozygous mice [27, 28] and reflects a reduction in
AMPA receptors, as they are constitutively active even
during basal conditions [54]. In fact, a decrease in
GluA1-immunoreactive puncta in CA1 was previously
reported in Shank3 heterozygous mice, indicating a de-
crease in AMPA receptors [27]. This is substantiated byensity. a Wildtype mice have silent synapses which are remodeled into
n increase in perforated synapses, which may not be remodeled into
ygous mice have impairments in LTP induction and maintenance, which
pensatory, does not occur. Black synapses indicate non-perforated
ns indicate perforated synapses. Red arrows indicate mechanisms that
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LTP, which is AMPA receptor-dependent [27].
The results of this study indicate that 5-week-old
Shank3 heterozygous mice have a significant increase in
perforated synapses. While the overall sample is sizeable
for an electron microscopy study, we do realize that an
n of 5 for each group is small; as such, the caveat that
the results may be due to a type I error does arise. In
order to resolve this issue, further research with a larger
population of mice will be necessary. Nevertheless, the
above results suggest the occurrence of a significant in-
crease in perforated spines accompanied by impaired
LTP maintenance [27] and of an increase in perforated
synapses, which may be providing some, yet insufficient,
compensation for an increased amount of silent, non-
functional synapses. The remodeling of perforated
synapses back into non-perforated synapses occurs dur-
ing LTP maintenance [50]; however, as LTP maintenance
is impaired, this remodeling may not occur, possibly
underlying the consistent increase in the amount of per-
forated synapses. The relative decrease in perforated
synapse density to “normal” levels in Shank3 heterozy-
gous mice at 3 months may be a reflection of a
normalization of functional activity with age, as silent
synapses can be transiently silent, thereby reducing the
need for perforated synapses. Notably, the Shank3
homozygous mice showed no difference in perforated
synapses at 5 weeks (Fig. 2b), despite the substantial
impairment in LTP. This may occur because perforated
synapses are formed during LTP induction [55], which
is significantly impaired in Shank3 homozygous mice;
this impairment may hinder the formation of perforated
synapses (see Fig. 5).
While there are no directly correlated studies on
synaptic morphology measures in individuals with aut-
ism or PMS in the hippocampus, there are several
studies that imply alterations at the synaptic level.
Neuropathology studies have revealed abnormalities in
neuronal numbers [1–6], and imaging studies have re-
vealed a variable degree of altered connectivity local-
ized to specific areas (e.g., [56, 57]). Additionally,
work at the protein level has shown abnormalities in
receptors in the hippocampus, which may reflect
changes at the synapse as well [58, 59]. In accordance
with these studies, it will be crucial to use electron
microscopy to assess whether there are changes in the
synapse at the protein level. Future studies will also
expand the age range in these mice, particularly at a
younger age as autism is a neurodevelopmental dis-
order; additionally, expanding the number of mice per
group will allow for stronger conclusions regarding
the synaptic alterations in these mice.Conclusions
This study examined whether synaptic pathology was
present in Shank3 heterozygous and Shank3 homozy-
gous mice at 5 weeks and 3 months of age. Shank3
heterozygous mice (5-weeks-old) had a statistically sig-
nificantly higher density of perforated synapses and no
change in other measured parameters (synapse density,
PSD length, PSD area, and spine head size); 3-month-
old mice had no changes across groups for any mea-
sured parameter. It is remarkable that there are so few
detectable behavioral and neuropathologic changes in
these Shank3 variant mice despite the loss of this dom-
inant scaffolding protein. These results highlight the
importance of seeking even more subtle alterations, in
the form of changes in specific protein levels, at the
synapses of these mice. Understanding the subtle ef-
fects of this single-locus cause of autism will provide a
framework for similar explorations in other genetic
causes associated with the disorder, which will allow us
to determine whether alterations in these disparate
genes lead to similar effects at the most basic functional
level, namely, the synapse.
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